Precigen
Utility Patent Applications

Last updated:

List of all Precigen patents 14 in total

Status Patent
Application
Utility: MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 May 2022
Application
Utility: MUC16 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 19 May 2022
Application
Utility: MOLECULAR SWITCHES External link
Filling date: 6 Sep 2025 Issue date: 14 Apr 2022
Application
Utility: METHODS AND MICROORGANISMS FOR MAKING 1,4-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: EXPRESSION OF NOVEL CELL TAGS External link
Filling date: 6 Sep 2025 Issue date: 3 Mar 2022
Application
Utility: METHODS AND MICROORGANISMS FOR MAKING 2,3-BUTANEDIOL AND DERIVATIVES THEREOF FROM C1 CARBONS External link
Filling date: 6 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: IN VIVO CONTROLLED COMBINATION THERAPY FOR TREATMENT OF CANCER External link
Filling date: 6 Sep 2025 Issue date: 23 Dec 2021
Application
Utility: EXPRESSION OF NOVEL CELL TAGS External link
Filling date: 6 Sep 2025 Issue date: 21 Oct 2021
Application
Utility: ROR-1 SPECIFIC CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF External link
Filling date: 6 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: FRATAXIN EXPRESSION CONSTRUCTS External link
Filling date: 6 Sep 2025 Issue date: 17 Jun 2021
Application
Utility: ELECTROPORATION APPARATUS AND METHOD External link
Filling date: 6 Sep 2025 Issue date: 13 May 2021
Application
Utility: HUMAN PAPILLOMAVIRUS VACCINES AND USES OF THE SAME External link
Filling date: 6 Sep 2025 Issue date: 28 Jan 2021
Application
Utility: HEPATITIS B VACCINES AND USES OF THE SAME External link
Filling date: 6 Sep 2025 Issue date: 21 Jan 2021
Application
Utility: MODULATING EXPRESSION OF POLYPEPTIDES VIA NEW GENE SWITCH EXPRESSION SYSTEMS External link
Filling date: 6 Sep 2025 Issue date: 10 Sep 2020

Showing 1 to 14 of 14 patents.